Beijing Libang Pharmaceutical

Beijing Libang Pharmaceutical is a specialized pharmaceutical company based in China, primarily focused on the research, development, and production of anesthesia and cardiovascular medications. The company is recognized for its expertise in lipid emulsion drug delivery technology, which it applies to improve the stability and reduce the side effects of injectable drugs. Its core product portfolio includes Propofol Medium/Long Chain Fat Emulsion and Etomidate Fat Emulsion, which are widely used in clinical anesthesia and sedation. Beyond anesthesia, the company produces treatments for cerebrovascular and peripheral vascular diseases, such as Nimodipine and Alprostadil injections. Beijing Libang operates state-of-the-art GMP-certified manufacturing facilities in Beijing to ensure high-quality production standards. As a subsidiary of the Xi'an Libang Pharmaceutical Group, it plays a critical role in the group's strategy to dominate the domestic injectable drug market.